Skip to main content
AMVUTTRA 25 mg/.5mL injection by Alnylam Pharmaceuticals, Inc.
AMVUTTRA, 25 mg/.5mL, injection Drug class: Small Interfering RNA; Transthyretin-directed RNA Interaction. Available on prescription only. Listed by Alnylam Pharmaceuticals, Inc..
Prescription only

AMVUTTRA

VUTRISIRAN

Listed by Alnylam Pharmaceuticals, Inc.

Strength
25 mg/.5mL
Form
Injection
Route
Subcutaneous
Class
Small Interfering RNA; Transthyretin-directed…

What it contains

  • Vutrisiran Sodium 25 mg/.5mL

FDA record

Dosage form Injection
Route Subcutaneous
Drug class Small Interfering RNA; Transthyretin-directed RNA Interaction
Approval route NDA — original brand approval
NDC code 71336-1003
FDA application NDA215515
RxNorm concept 2604788
Package sizes listed 1
Marketed since June 2022

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.